“Use of rhGH in children with chronic kidney disease: lessons from NAPRTCS.”, Pediatr Nephrol, vol. 22, no. 8, pp. 1195-204, 2007.
, “Use of rhGH in Children with Chronic Kidney Disease: Lessons from NAPRTCS”, Pediatr Nephrol, vol. 22, pp. 1195-1204, 2007.
, “Use of Population Modeling to Characterize the Pharmacokinetics of Oxcarbazepine And Its Metabolite in Children and Adolescents with Obesity”, in Annual Meeting of American Society for Clinical Pharmacology and Therapeutics (ASCPT), Virtual, 2022.
, “Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescents.”, Clin Pharmacol Ther, vol. 96, no. 4, pp. 429-37, 2014.
, “Use of Opportunistic Clinical Data and a Population Pharmacokinetic Model to Support Dosing of Clindamycin for Premature Infants to Adolescents”, Clin Pharmacol Ther, vol. 96, pp. 429-437, 2014.
, , “Use of low-dose tacrolimus and associated hypomagnesemia in the prevention of erectile dysfunction following prostatectomy for prostate cancer.”, Pharmacol Rep, vol. 68, no. 6, pp. 1154-1158, 2016.
, “Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-bli”, Lancet Infect Dis, vol. 16, no. 1, pp. 31-42, 2016.
, “Use of biological assignment in hematopoietic stem cell transplantation clinical trials.”, Clin Trials, vol. 5, no. 6, pp. 607-16, 2008.
, “Use of Biological Assignment in Hematopoietic Stem Cell Transplantation Clinical Trials”, Clin Trials, vol. 5, pp. 607-616, 2008.
, “Use of a prescription opioid registry to examine opioid misuse and overdose in an integrated health system.”, Prev Med, vol. 110, pp. 31-37, 2018.
, “Updates to the National Institute of Neurological Disorders and Stroke (NINDS) Spinal Cord Injury (SCI) Common Data Element Recommendations”, in International Spinal Cord Society 59th Annual Scientific Virtual Meeting, Virtual, 2020.
, “Updates to the National Institute of Neurological Disorders and Stroke (NINDS) Multiple Sclerosis (MS) Common Data Element (CDE) Recommendations: 2018 MS Oversight Committee (OC) Review”, in American Academy of Neurology 71st Annual Meeting, Philadelphia, PA, 2019.
, , “Updates to the National Institute of Neurological Disorders and Stroke (NINDS) Cerebral Palsy Common Data Elements: Participant Condition Characteristics.”, in PUB:American Academy for Cerebral Palsy and Developmental Medicine 74th Annual Virtual Meeting, Virtual Live Conference, 2020.
, “Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0.”, J Clin Oncol, p. JCO2003613, 2021.
, “Updated multivariate analyses of patient characteristics as predictors of survival in hormone-refractory prostate cancer patients treated with suramin”, Cancer Epidemiology, Biomarkers & Prevention, vol. 7, pp. 631-34, 1998.
, “Update from studies in pediatric liver transplantation.”, Transplant Proc, vol. 33, no. 7-8, pp. 3604-5, 2001.
, “Untitled”, 2000.
, “Untitled”, 2001.
“Untitled”, 2004.
, “Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).”, Biol Blood Marrow Transplant, vol. 18, no. 8, pp. 1265-72, 2012.
, “Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)”, Biol Blood Marrow Transplant, vol. 18, pp. 1265-1272, 2012.
, “Understanding hospital readiness for computerized physician order entry.”, Jt Comm J Qual Saf, vol. 29, no. 7, pp. 336-44, 2003.
, “Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya.”, AIDS Behav, vol. 19, no. 5, pp. 794-801, 2015.
,